R O Santos
Overview
Explore the profile of R O Santos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castillo N, Santos R, James W, Rezek R, Cerveny D, Boucek R, et al.
Mar Pollut Bull
. 2024 Oct;
209(Pt A):117143.
PMID: 39461181
Pharmaceuticals have been acknowledged as an important contaminant of emerging concern with the potential to cause adverse effects in exposed fauna. Most research has focused on temperate freshwater systems; therefore,...
2.
Castillo N, Santos R, James W, Rezek R, Cerveny D, Boucek R, et al.
Aquat Toxicol
. 2024 Aug;
275:107064.
PMID: 39208620
To date, the presence of pharmaceuticals has been extensively documented across a wide range of aquatic systems and biota. Further, substantial progress has been made in transitioning from laboratory assessments...
3.
Castillo N, James W, Santos R, Rezek R, Cerveny D, Boucek R, et al.
J Hazard Mater
. 2024 Aug;
477:135382.
PMID: 39088947
Pharmaceutical uptake involves processes that vary across aquatic systems and biota. However, single studies examining multiple environmental compartments, microhabitats, biota, and exposure pathways in mesoconsumer fish are sparse. We investigated...
4.
Castillo N, James W, Santos R, Rezek R, Cerveny D, Boucek R, et al.
Chemosphere
. 2023 Dec;
349:140949.
PMID: 38096990
Most research on pharmaceutical presence in the environment to date has focused on smaller scale assessments of freshwater and riverine systems, relying mainly on assays of water samples, while studies...
5.
Neves M, Ohe M, Rosano M, Abrahao M, Cervantes O, Lazaretti-Castro M, et al.
J Osteoporos
. 2012 Apr;
2012:914214.
PMID: 22523718
Introduction. Primary hyperparathyroidism (PHP) is characteristically determined by high levels of calcium and high or inappropriate levels of parathyroid hormone (PTH). Technological advances have dramatically changed the surgical technique over...
6.
Santos R, Ohe M, Carvalho A, Neves M, Kunii I, Lazaretti-Castro M, et al.
J Osteoporos
. 2012 Apr;
2012:631243.
PMID: 22496985
Surgical treatment of secondary (SHPT) and tertiary hyperparathyroidism (THPT) may involve various surgical approaches. The aim of this paper was to evaluate presternal intramuscular autotransplantation of parathyroid tissue as a...
7.
Oliveira U, Ohe M, Santos R, Cervantes O, Abrahao M, Lazaretti-Castro M, et al.
Braz J Med Biol Res
. 2007 Apr;
40(4):519-26.
PMID: 17401495
Primary hyperparathyroidism is an endocrine disorder with variable clinical expression, frequently presenting as asymptomatic hypercalcemia in Western countries but still predominantly as a symptomatic disease in developing countries. The objective...
8.
Ohe M, Santos R, Barros E, Lage A, Kunii I, Abrahao M, et al.
Braz J Med Biol Res
. 2005 Sep;
38(9):1383-7.
PMID: 16138222
In contrast to most developed countries, most patients with primary hyperparathyroidism in Brazil are still symptomatic at diagnosis. However, we have been observing a change in this pattern, especially in...
9.
Ohe M, Santos R, Kunii I, Carvalho A, Abrahao M, Cervantes O, et al.
Braz J Med Biol Res
. 2003 Jun;
36(6):715-21.
PMID: 12792700
Intraoperative parathyroid hormone (IO-PTH) measurements have been proposed to improve operative success rates in primary, secondary and tertiary hyperparathyroidism (PHP, SHP and THP). Thirty-one patients requiring parathyroidectomy were evaluated retrospectively...
10.
Abrahao M, Goncalves A, Yamashita R, Dedivitis R, Santos R, Nascimento L, et al.
Sao Paulo Med J
. 2000 Jul;
118(4):118-20.
PMID: 10887389
Context: Paranasal sinus cancer is considered rare, with an incidence of less than 1 per 100,000 per year, with the frontal sinus being the primary site in only 0.3%. We...